Vector Biomed

Other Pharmaceuticals and Biotechnology

Vector Biomed is a private other pharmaceuticals and biotechnology company. It has raised $15 million across 1 recorded round; the latest was a $15 million Series A in Jan 2023.

Last price · $/share
—
Implied valuation
—
Total raised
$15.0M
Last round
Early Stage VC (Series A)
Jan 2023

Vector Biomed key facts

  • It has raised $15.0M across 1 recorded rounds; the latest was Early Stage VC (Series A) ($15.0M) in Jan 2023.
  • Vector Biomed has filed 1 Form D with the SEC, most recently Dec 2022 ($7.5M sold to 3 investors).
Free account
More of Vector Biomed with a free account
  • ·Watch Vector Biomed: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Vector Biomed funding rounds

1 rounds
Jan 2023Early Stage VC (Series A)$15.0M▮

How much has Vector Biomed raised?

Vector Biomed has raised $15 million across 1 recorded round since 2023. The largest was a $15 million Series A in Jan 2023.

Vector Biomed has filed 1 Form D with the SEC, most recently in Dec 2022 ($7.5 million sold to 3 investors).

About Vector Biomed

Industry
Other Pharmaceuticals and Biotechnology

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation — not yet priced

Vector Biomed doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.